Literature DB >> 16600075

Cardiac troponin I is a sensitive, specific biomarker of cardiac injury in laboratory animals.

P J O'Brien1, D E C Smith, T J Knechtel, M A Marchak, I Pruimboom-Brees, D J Brees, D P Spratt, F J Archer, P Butler, A N Potter, J P Provost, J Richard, P A Snyder, W J Reagan.   

Abstract

This study directly demonstrates that cardiac troponin I (cTnI) is a sensitive, specific, and persistent biomarker in laboratory animals. Histopathological and pathophysiological cardiac changes in dogs, rats and mice correlated with increased serum cTnI with various cardiac inotropic agents, and cardiotoxic drugs and with cardiac arrhythmias, tachycardia, cardiac effusion with dyspnoea, and ageing. A comparison of six immunoassays for cTnI and cardiac troponin T (cTnT) to detect and monitor cardiac injury in a rodent model indicated that enzyme-linked immunosorbent (Life Diagnostics Inc and TriChem Resources Inc, West Chester, Philadelphia, USA) and Immulite (Diagnostic Products Corporation, Llanberis, UK) assays had low sensitivity and less than 1% of the dynamic range of Centaur (Bayer Healthcare Diagnostics, Newbury, UK) cTnI and Elecsys (Roche Diagnostics, Basel, Switzerland) and M8 (Bioveris Europe, Whitney, UK) cTnT assays. In dogs, however, the Immulite assay was effective and correlated with the Centaur. Serum concentrations were highly correlated but 10-fold lower for cTnT compared with cTnI with cardiac injury. Centaur assay also detected cTnI in myocardium from marmosets, swine, cattle, and guinea pigs, indicating it to be candidate cardiac biomarker for these species as well. Purified rat cTnI was 50% more reactive than purified human cTnI in the Centaur assay. In the rat, an age- and gender-dependent variation in serum cTnI was found. Male rats aged six and eight months had a 10-fold greater serum cTnI than age-matched females and three-month-old rats. These increases correlated with minimal histopathological change. Isoproterenol-induced serum cTnI increased up to 760-fold the minimal detectable concentration of 0.07 microg/L, within 4-6 h and decreased with a half-life of 6 h, with an expected return to baseline of 60 h. Severity of histopathological change correlated with serum cTnI during the ongoing injury.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16600075     DOI: 10.1258/002367706776319042

Source DB:  PubMed          Journal:  Lab Anim        ISSN: 0023-6772            Impact factor:   2.471


  59 in total

1.  Bioreducible polymer-transfected skeletal myoblasts for VEGF delivery to acutely ischemic myocardium.

Authors:  Arlo N McGinn; Hye Yeong Nam; Mei Ou; Norman Hu; Catherine M Straub; James W Yockman; David A Bull; Sung Wan Kim
Journal:  Biomaterials       Date:  2010-11-05       Impact factor: 12.479

2.  Red ginseng (Panax ginseng) decreases isoproterenol-induced cardiac injury via antioxidant properties in porcine.

Authors:  Kyu Hee Lim; Jae Youl Cho; Bumseok Kim; Bong-Seuk Bae; Jong-Hoon Kim
Journal:  J Med Food       Date:  2014-01       Impact factor: 2.786

3.  Effect of racing on the serum concentrations of cardiac troponin I and creatine kinase myocardial band in racing camels (Camelus dromedarius).

Authors:  Mohamed Tharwat; Fahd Al-Sobayil; Sébastien Buczinski
Journal:  Vet Res Commun       Date:  2013-02-24       Impact factor: 2.459

4.  Evaluation of cardiac troponin I in dogs presenting to the emergency room using a point-of-care assay.

Authors:  Adam Porter; Elizabeth Rozanski; Lori Lyn Price; Scott Shaw
Journal:  Can Vet J       Date:  2016-06       Impact factor: 1.008

5.  In vivo opening of the mitochondrial permeability transition pore in a rat model of ventricular fibrillation and closed-chest resuscitation.

Authors:  Iyad M Ayoub; Jeejabai Radhakrishnan; Raúl J Gazmuri
Journal:  Am J Transl Res       Date:  2017-07-15       Impact factor: 4.060

6.  Bovine tricuspid endocarditis as a cause of increased serum concentration of cardiac troponins.

Authors:  Sébastien Buczinski; Anne-Marie Bélanger
Journal:  Can Vet J       Date:  2010-02       Impact factor: 1.008

7.  Evaluation of potential acute cardiotoxicity of biodegradable nanocapsules in rats by intravenous administration.

Authors:  Rafael Fracasso; Marília Baierle; Gabriela Goëthel; Anelise Barth; Fernando Freitas; Sabrina Nascimento; Louise Altknecht; Virgilio Olsen; Karina Paese; Vinicius Duval da Silva; Iran Castro; Michael Andrades; Nadine Clausell; Adriana Pohlmann; Silvia Guterres; Solange Cristina Garcia
Journal:  Toxicol Res (Camb)       Date:  2015-10-05       Impact factor: 3.524

8.  B-type natriuretic peptide and adiponectin releases in rat model of myocardial damage induced by isoproterenol administration.

Authors:  Sabaheta Hasić; Almira Hadžović-Džuvo; Radivoj Jadrić; Emina Kiseljaković
Journal:  Bosn J Basic Med Sci       Date:  2013-11       Impact factor: 3.363

9.  Experimental model of transthoracic, vascular-targeted, photodynamically induced myocardial infarction.

Authors:  Adrian Chrastina; Peter Pokreisz; Jan E Schnitzer
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-11-08       Impact factor: 4.733

10.  Cardioprotection from ischemia-reperfusion injury by near-infrared light in rats.

Authors:  Brendan J Quirk; Purabi Sonowal; Mohammad-Ali Jazayeri; John E Baker; Harry T Whelan
Journal:  Photomed Laser Surg       Date:  2014-08-05       Impact factor: 2.796

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.